EMA’s New 2019 Guideline on Sterilization of The Medicinal Products, Its Potential Impact on FDA’s Sterilization Thinking and Its Comparison to USP, PDA and Health Canada Methods

Live, Interactive Training Webinar

Date: Tuesday February 4, 2020 - Time: 10:30 AM - 12:30 PM ET
Barry A. Friedman Ph.D. Biography>>>

Member Registration ►

Registration Form ►

The European Medicines Agency (EMA) recently published “Sterilization of the Medicinal Product, Active Substance, Excipient and Primary Container” in March 2019 which has an effective date of October 2019.
This new Guidance should have a dramatic impact on the FDA’s sterilization thinking since it strongly suggests that there are alternatives, i.e., Advanced Therapy Medicinal Products (ATMPs), to standard terminal sterilization standards of 121oC for 15 minutes.
This new guidance discusses the choice of selective methods of sterilization of sterile products. It also reviews the use of terminal sterilization and the importance of alternative methods for manufacturing sterile products when terminal sterilization will cause degradation. Where terminal sterilization is not possible, an alternative must be developed that includes the rationale of ICH Q9 - Quality Risk Management. For new products, the guidance provides the appropriate decision-making process within several tables for the sterilization of various final product forms, e.g., aqueous, powder, pellets. Again, Quality Risk Management and its elements are essential to the decision-making process.

This guidance will also be compared and contrasted to various current FDA, PDA, Health Canada and USP documents to include: 1) FDA Guidance for Industry: Sterile Drug Products Produced by Aseptic Processing — Current Good Manufacturing Practice (September 2004), 2) PDA Technical Report #33 Evaluation, Validation and Implementation of Alternative and Rapid Microbial Methods, 3) Health Canada “Process Validation: Moist Heat Sterilization for Pharmaceuticals”, 4) USP<1116> Microbiological Control of Aseptic Processing Environments and Its Implications (2012).

The objective of this live and interactive training webinar is to explore the use of various modes of sterilization to include new concepts that involve both aseptic filling combined with terminal sterilization, and learn how they may be used within your current manufacturing operation to provide both sterile components and final product. Please plan to attend this webinar as a team activity to get the most from this discussion.

Learning Benefits:
- Learning of the Requirements for the manufacture of sterile medicinal products and their components
- Choices available for sterilization to include both terminal and aseptic processing sequentially
- Issues to consider when processing aqueous products
- Issues to consider when processing dry powders, non-aqueous and semi-solid products
- Risk/benefit consideration evaluation when choosing a sterilization mode
- Use of Decisions Trees to assist in the selection of the optimal sterilization method

Webinar outline and time breakdown:

10:15 AM Log In Period
10:30 AM Introduction
10:40 AM Review of the various modes of terminal sterilization to include steam, dry heat and ionizing,
Review of the various modes of sterile filtration and aseptic processing,
Issues to consider when processing aqueous products,
11:30 AM Break
11:40 AM Issues to consider when processing dry powders, non-aqueous and semi-solid products,
Risk/benefit consideration evaluation when choosing a sterilization mode,
Use of Decision Trees to assist in the selection of the optimal sterilization mode,
Review of Pertinent Case Studies/Warning Letters,
12:30 PM Live Questions & Discussion

*Please note all times are Eastern Time (New York Time)

This live training webinar includes the following for each registered attendee:

  • A copy of the presentation slides
  • A certificate of training for attendee records

Who should attend:
The following individuals or disciplines will benefit from attending this Webinar:

  • Manufacturing
  • Quality
  • Quality Control
  • Validation
  • R&D

Registration Form ►

Instructor: Barry A. Friedman Ph.D.

Barry A. Friedman, Ph.D., is a Senior Consultant in the Biotechnology, Regulatory Compliance and Aseptic Processing arena. Dr. Friedman is a frequent seminar speaker in the GMP areas of internal auditing, aseptic processing of sterile drug products, USP microbiology, validations and the requirements for the manufacture of Phase 1, 2 and 3 clinical trial materials. He has recently given presentations for the FDA, PDA, PTi. He is a member of AAMI, ASM, PDA and RAPS. He served as a Captain in the Medical Service Corps, U.S. Army and is the past President of the Capital Area Chapter, PDA... Full Bio>>>



Course Number: 233

System Requirements:

All Pharma Webinars live training programs audio and visual are delivered via Cisco WebEx with basic system requirements of a computer with internet access and a telephone to access the audio portion of the presentations. You can choose to access the audio through your computer.

Live Training Benefits:

• Pharma Webinars training webinars and programs are presented exclusively as live events only.

• Designed and delivered based on e-learning best practices, Pharma Webinars' live training webinars and programs are as effective as in person training.

• Live training webinars and multi-part training programs are strictly educational based, and do not promote or endorse any products or services whatsoever.

• An interactive live Q&A and discussion period is included in each live training presentation. Questions can also be submitted to the speaker via email both prior to and following the live training webinar as a means of improving participant experience, and ensuring successful topic comprehension.

• Live presentations ensure that all live training webinars and programs are engaging and informative, allowing trainees to exchange ideas through audio conferencing and live chat during each presentation in real time. Each live training session includes a dedicated live Q&A period allowing trainees to interact directly with the instructor, with quick feedback providing them with concrete understanding of the answers and the training subject itself.

• Each Pharma Webinars live training webinar and program content is updated on regular basis to provide the latest regulatory, operational and technological trends in the international pharmaceutical arena. As regulatory expectations, guidance, or industry trends change, so does our training in order to reflect those changes as soon as the changes are released.

• Pharma Webinars' instructors are the most recognized subject matter experts in the industry who are selected based on very strict qualification criteria. They are coached on the latest e-learning speaking methods in order to make each presentation engaging, memorable and very effective.

• Each registered attendee receives an exact copy of the presentation slides and other course handouts significantly reducing the learning curve as trainees can refer back to this material in the future.

• All trainees receive a Certificate of Attendance for each live training webinar and program they attend to be kept for training records.

Client Testimonials:

"The live webinar was very useful to our team, the content was relevant and the instructor was very knowledgeable" QC Microbiology Supervisor, NJ

"We were very satisfied with the live presentation; we appreciated the speaker staying on to answer all of our questions" QA Director, MA

"Our group enjoyed the live presentation and found the experience much more engaging and worthwhile than any recorded webcasts" Sr Training Manager, CA

"This was my first live training, I found it easy to connect, participate and very useful" Laboratory Analyst, PA

"We had our entire department attend this training program and found it to be very useful, I am very satisfied with the speaker's ability to keep the audience engaged" QC Manager, NY

"Given how recent the content of the webinar was, our team members were very happy with the relevance of the training" VP Clinical Operations, CA

"Is my first time to attend training, I enjoy it very much" Sr Manager, Korea

"Our department found the level of interactivity between the audience and the instructor far beyond that of any other online training that we have attended before. Well done" Director Regulatory Affairs, ON

"Our interest group was spread out over three locations and we were able to participate simultaneously and interact very easily" Lead Compliance Manager, IL

"Well satisfied with the presentation. Our team found the speaker's level of knowledge and his ability to translate that knowledge to our processes very valuable" VP Quality Operations, NC

"We were impressed with the quality of the presentation, and despite our being located in Europe we were able to participate without a hitch" QC Manager, Ireland